litlas
ログインアカウント作成

Werner Scheithauer

1985–2022 年に発表

80
論文数
29,170
被引用数
67
h 指数
80
i10 指数

被引用数

Werner Scheithauer の年別被引用数1952 年: 被引用 1 件1985 年: 被引用 2 件1986 年: 被引用 8 件1987 年: 被引用 4 件1988 年: 被引用 4 件1989 年: 被引用 6 件1990 年: 被引用 2 件1991 年: 被引用 8 件1992 年: 被引用 2 件1993 年: 被引用 3 件1994 年: 被引用 4 件1995 年: 被引用 16 件1996 年: 被引用 17 件1997 年: 被引用 17 件1998 年: 被引用 15 件1999 年: 被引用 25 件2000 年: 被引用 19 件2001 年: 被引用 27 件2002 年: 被引用 36 件2003 年: 被引用 24 件2004 年: 被引用 58 件2005 年: 被引用 81 件2006 年: 被引用 54 件2007 年: 被引用 87 件2008 年: 被引用 135 件2009 年: 被引用 202 件2010 年: 被引用 267 件2011 年: 被引用 201 件2012 年: 被引用 233 件2013 年: 被引用 184 件2014 年: 被引用 221 件2015 年: 被引用 226 件2016 年: 被引用 209 件2017 年: 被引用 270 件2018 年: 被引用 225 件2019 年: 被引用 860 件2020 年: 被引用 861 件2021 年: 被引用 814 件2022 年: 被引用 490 件2023 年: 被引用 347 件2024 年: 被引用 544 件2025 年: 被引用 196 件2026 年: 被引用 7 件1953〜1984 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,709 件、この内訳の 19%中国: 引用元論文 803 件、この内訳の 9%イタリア: 引用元論文 726 件、この内訳の 8.1%イギリス: 引用元論文 578 件、この内訳の 6.4%ドイツ: 引用元論文 572 件、この内訳の 6.4%フランス: 引用元論文 540 件、この内訳の 6%日本: 引用元論文 431 件、この内訳の 4.8%スペイン: 引用元論文 360 件、この内訳の 4%オランダ: 引用元論文 352 件、この内訳の 3.9%ベルギー: 引用元論文 246 件、この内訳の 2.7%カナダ: 引用元論文 232 件、この内訳の 2.6%オーストラリア: 引用元論文 217 件、この内訳の 2.4%
0%19%その他 24.7%

機関

分野

  • Medicine79.8%
  • Biochemistry, Genetics and Molecular Biology13%
  • Immunology and Microbiology2.4%
  • Computer Science1.4%
  • Neuroscience0.7%
  • Materials Science0.7%
  • その他2%

トピック

  • Colorectal Cancer Treatments and Studies12.9%
  • Hepatocellular Carcinoma Treatment and Prognosis5.7%
  • Pancreatic and Hepatic Oncology Research5.3%
  • Colorectal Cancer Surgical Treatments5.2%
  • Cancer Genomics and Diagnostics3.6%
  • Genetic factors in colorectal cancer3.6%
  • その他63.7%

共著者

全論文

検索で開く
  1. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

    著者: Eric Van Cutsem, Andrés Cervantes, René Adam, Alberto Sobrero, J. Han van Krieken, Dan Aderka, E. Aranda Aguilar, Alberto Bardelli, Al B. Benson, G. Bodoky, Fortunato Ciardiello, André D’Hoore, Eduardo Díaz‐Rubio, Jean‐Yves Douillard, Michel Ducreux, Alfredo Falcone, Axel Grothey, Thomas Gruenberger, Karin Haustermans, Volker Heinemann, Paulo M. Hoff, C.-H. Köhne, Roberto Labianca, Pierre Laurent‐Puig, Brigette Ma, Tim Maughan, Kei Muro, Nicola Normanno, Pia Österlund, Wim J.G. Oyen, Demetris Papamichael, George Pentheroudakis, Per Pfeiffer, Timothy Price, Cornelis J.A. Punt, Jens Ricke, A. Roth, Ramón Salazar, Werner Scheithauer, Hans‐Joachim Schmoll, Josep Tabernero, Julien Taı̈eb, Sabine Tejpar, Harpreet Wasan, Takayuki Yoshino, Aziz Zaanan, Dirk Arnold - Annals of Oncology 2016 被引用: 3,449

  2. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial

    著者: Volker Heinemann, Ludwig Fischer von Weikersthal, Thomas Decker, Alexander Kiani, Ursula Vehling‐Kaiser, Salah‐Eddin Al‐Batran, Tobias Heintges, Christian Lerchenmüller, Christoph Kahl, G. Seipelt, Frank Kullmann, Martina Stauch, Werner Scheithauer, Jörg Hielscher, Michael Scholz, Sebastian Müller, Hartmut Link, N. Niederle, A. Rost, Heinz‐Gert Höffkes, Markus Moehler, Reinhard Udo Lindig, Dominik Paul Modest, Lisa Rossius, Thomas Kirchner, Andreas Jung, Sebastian Stintzing - The Lancet Oncology 2014 被引用: 1,741

  3. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

    著者: Bernard Nordlinger, Halfdan Sørbye, Bengt Glimelius, Graeme J. Poston, Peter M. Schlag, Philippe Rougier, Wolf O. Bechstein, John N Primrose, Euan Walpole, Meg Finch-Jones, Daniel Jaeck, Darius Mirza, Rowan W. Parks, Murielle Mauer, E. Tanis, Eric Van Cutsem, Werner Scheithauer, Thomas Gruenberger - The Lancet Oncology 2013 被引用: 1,316

  4. Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study

    著者: Thierry André, Armand de Gramont, Déwi Vernerey, Benoist Chibaudel, Franck Bonnetain, Annemilaï Tijeras‐Raballand, Aurélie Scriva, Tamas Hickish, Josep Tabernero, Jean‐Luc Van Laethem, Maria Banzi, E. Maartense, Einat Shmueli, Göran Carlsson, Werner Scheithauer, Demetris Papamichael, M. Moehler, Stefania Landolfi, Pieter Demetter, Soudhir Colote, Christophe Tournigand, Christophe Louvet, Alex Duval, Jean-François Fléjou, Aimery de Gramont - Journal of Clinical Oncology 2015 被引用: 675

  5. Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

    著者: Leonard B. Saltz, Stephen Clarke, Eduardo Díaz‐Rubio, Werner Scheithauer, Arié Figer, Ralph Wong, Sheryl Koski, Mikhail Lichinitser, Tsai‐Shen Yang, Fernando Rivera, Félix Couture, Florin Sirzén, Jim Cassidy - Journal of Clinical Oncology 2008 被引用: 2,963

  6. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

    著者: Hans‐Joachim Schmoll, Eric Van Cutsem, Alexander Stein, Vincenzo Valentini, Bengt Glimelius, Karin Haustermans, Bernard Nordlinger, Cornelis JH van de Velde, Judith Balmañà, Jarosław Reguła, Irıs D. Nagtegaal, Geerard L. Beets, Dirk Arnold, Fortunato Ciardiello, Paulo M. Hoff, David J. Kerr, C.-H. Köhne, Roberto Labianca, Timothy Price, Werner Scheithauer, Alberto Sobrero, Josep Tabernero, Dan Aderka, Sérgio Barroso, G. Bodoky, Jean‐Yves Douillard, Hesham El Ghazaly, J. Gallardo, A. Garin, Rob Glynne‐Jones, Karin Jordan, Andrey Meshcheryakov, Demetris Papamichail, Per Pfeiffer, Ioannis Souglakos, Serdar Turhal, Andrés Cervantes - Annals of Oncology 2012 被引用: 1,534

  7. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

    著者: Bernard Nordlinger, Halfdan Sørbye, Bengt Glimelius, Graeme J. Poston, Peter M. Schlag, Philippe Rougier, Wolf O. Bechstein, John N Primrose, Euan Walpole, Meg Finch-Jones, Daniel Jaeck, Darius Mirza, Rowan W. Parks, Laurence Collette, Michel Praet, Ullrich Bethe, Eric Van Cutsem, Werner Scheithauer, Thomas Gruenberger - The Lancet 2008 被引用: 1,945

  8. FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial

    著者: Volker Heinemann, Ludwig Fischer von Weikersthal, Thomas Decker, Alexander Kiani, Florian Kaiser, Salah-Edin Al-Batran, Tobias Heintges, Christoph Lerchenmüller, Christoph Kahl, G. Seipelt, Frank Kullmann, Markus Moehler, Werner Scheithauer, Swantje Held, Lisa Miller‐Phillips, Dominik Paul Modest, Andreas Jung, Thomas Kirchner, Sebastian Stintzing - British Journal of Cancer 2020 被引用: 188

  9. nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial

    著者: David Goldstein, Robert H. El-Maraghi, Pascal Hammel, Volker Heinemann, Volker Kunzmann, Javier Sastre, Werner Scheithauer, Salvatore Siena, Josep Tabernero, Luís Teixeira, Giampaolo Tortora, Jean‐Luc Van Laethem, Rosemary Young, Darryl Penenberg, Brian Lu, Alfredo Romano, Daniel D. Von Hoff - JNCI Journal of the National Cancer Institute 2015 被引用: 663

  10. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial

    著者: Sebastian Stintzing, Dominik Paul Modest, Lisa Rossius, Markus M. Lerch, Ludwig Fischer von Weikersthal, Thomas Decker, Alexander Kiani, Ursula Vehling‐Kaiser, Salah‐Eddin Al‐Batran, Tobias Heintges, Christian Lerchenmüller, Christoph Kahl, G. Seipelt, Frank Kullmann, Martina Stauch, Werner Scheithauer, Swantje Held, Clemens Gießen-Jung, Markus Moehler, A. Jagenburg, Thomas Kirchner, Andreas Jung, Volker Heinemann - The Lancet Oncology 2016 被引用: 418

  11. Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality

    著者: Noémi Pávó, Markus Raderer, Martin Hülsmann, Stephanie Neuhold, Christopher Adlbrecht, Guido Strunk, Georg Goliasch, Heinz Gisslinger, Günther Steger, Michael Hejna, Wolfgang J. Köstler, Sabine Zöchbauer‐Müller, Christine Marosi, Gabriela Kornek, Leo Auerbach, Sven Schneider, Bernhard Parschalk, Werner Scheithauer, Robert Pirker, Johannes Drach, Christoph Zielinski, Richard Pacher - Heart 2015 被引用: 270

  12. Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer

    著者: David Cunningham, Ian Chau, Deborah Stocken, Juan W. Valle, David B. Smith, William P. Steward, Peter Harper, Janet Dunn, Catrin Tudur Smith, Julia West, Stephen Falk, A. Crellin, F. Adab, Joyce Thompson, Pauline Leonard, J. Ostrowski, Martin Eatock, Werner Scheithauer, Richard Herrmann, John P. Neoptolemos - Journal of Clinical Oncology 2009 被引用: 818

  13. Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial

    著者: Sebastian Stintzing, Pratyaksha Wirapati, Heinz‐Josef Lenz, Daniel Neureiter, Ludwig Fischer von Weikersthal, Thomas Decker, Alexander Kiani, Florian Kaiser, Salah‐Eddin Al‐Batran, Tobias Heintges, Christian Lerchenmüller, Christoph Kahl, G. Seipelt, Frank Kullmann, Markus Moehler, Werner Scheithauer, Swantje Held, Dominik Paul Modest, Andreas Jung, Thomas Kirchner, Dan Aderka, Sabine Tejpar, Volker Heinemann - Annals of Oncology 2019 被引用: 194

  14. Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer

    著者: Eric Van Cutsem, Walter L. Vervenne, Jaafar Bennouna, Yves Humblet, Sharlene Gill, Jean‐Luc Van Laethem, Chris Verslype, Werner Scheithauer, Aijing Shang, Jan Cosaert, Malcolm J. Moore - Journal of Clinical Oncology 2009 被引用: 643

  15. Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

    著者: Jim Cassidy, Stephen Clarke, Eduardo Díaz‐Rubio, Werner Scheithauer, Arié Figer, Ralph Wong, Sheryl Koski, Mikhail Lichinitser, Tsai‐Shen Yang, Fernando Rivera, Félix Couture, Florin Sirzén, Leonard B. Saltz - Journal of Clinical Oncology 2008 被引用: 864

  16. EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer

    著者: Alberto Sobrero, Joan Maurel, Louis Fehrenbacher, Werner Scheithauer, Yousif Abubakr, Manfred P. Lutz, M. E. Vega-Villegas, Cathy Eng, E.U. Steinhauer, Jana Prausová, Heinz‐Josef Lenz, Christophe Borg, Gary Middleton, H. Kröning, Gabriele Luppi, O. Kisker, Angela Zubel, Christiane Langer, Justin Kopit, Howard A. Burris - Journal of Clinical Oncology 2008 被引用: 952

  17. Microparticle‐associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients

    著者: J. Thaler, Cihan Ay, Nigel Mackman, Rogier M. Bertina, Alexandra Kaider, Christine Marosi, Nigel S. Key, D. Anthony Barcel, Werner Scheithauer, Gabriela Kornek, Christoph Zielinski, Ingrid Pabinger - Journal of Thrombosis and Haemostasis 2012 被引用: 269

  18. Impact of BRAF and RAS mutations on first-line efficacy of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab: analysis of the FIRE-3 (AIO KRK-0306) study

    著者: Sebastian Stintzing, Lisa Miller‐Phillips, Dominik Paul Modest, Ludwig Fischer von Weikersthal, Thomas Decker, Alexander Kiani, Ursula Vehling‐Kaiser, S-E. Al-Batran, Tobias Heintges, Christoph Kahl, G. Seipelt, Frank Kullmann, Martina Stauch, Werner Scheithauer, Swantje Held, Markus Moehler, A. Jagenburg, Thomas Kirchner, Andreas Jung, Volker Heinemann - European Journal of Cancer 2017 被引用: 139

  19. Capecitabine as Adjuvant Treatment for Stage III Colon Cancer

    著者: Chris Twelves, A. Wong, Marek P. Nowacki, Markus Abt, Howard A. Burris, Alfredo Carrato, Jim Cassidy, Andrés Cervantes, Jan Fagerberg, Vassilis Georgoulias, Fares Husseini, Duncan I. Jodrell, P. Koralewski, H. Kröning, Jean A. Maroun, Norbert Marschner, Joseph McKendrick, Marek Pawlicki, Riccardo Rosso, Johannes Schüller, Jean‐François Seitz, Borut Štabuc, Jerzy Tujakowski, Guy van Hazel, J. Załuski, Werner Scheithauer - New England Journal of Medicine 2005 被引用: 1,247

  20. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.

    著者: Werner Scheithauer, Harald Rosén, Gabriela Kornek, Christian Sebesta, D. Depisch - BMJ 1993 被引用: 659

  21. XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results

    著者: J Cassidy, Stephen Clarke, Eduardo Díaz‐Rubio, Werner Scheithauer, Arié Figer, Ralph Wong, Sheryl Koski, Karen Rittweger, Frank Gilberg, Leonard B. Saltz - British Journal of Cancer 2011 被引用: 227

  22. Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

    著者: Richard Herrmann, G. Bodoky, Thomas Ruhstaller, Bengt Glimelius, Emilio Bajetta, Johannes Schüller, Piercarlo Saletti, Jean Bauer, Arié Figer, Bernhard C. Pestalozzi, Claus‐Henning Köhne, Walter Mingrone, Salomon M. Stemmer, Karin Rita Tamas, Gabriela Kornek, Dieter Koeberle, Susanne Cina, Jürg Bernhard, Daniel Dietrich, Werner Scheithauer - Journal of Clinical Oncology 2007 被引用: 591

  23. CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial

    著者: Viviane Hess, Bengt Glimelius, Philipp Grawe, Daniel Dietrich, G. Bodoky, Thomas Ruhstaller, Emilio Bajetta, Piercarlo Saletti, Arié Figer, Werner Scheithauer, Richard Herrmann - The Lancet Oncology 2008 被引用: 238

  24. Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial

    著者: Arndt Stahler, Sebastian Stintzing, Jobst C. von Einem, C. Benedikt Westphalen, Kathrin Heinrich, Nicole Krämer, Marlies Michl, Dominik Paul Modest, Ludwig Fischer von Weikersthal, Thomas Decker, Alexander Kiani, Tobias Heintges, Christoph Kahl, Frank Kullmann, Werner Scheithauer, Markus Moehler, Florian Kaiser, Thomas Kirchner, Andreas Jung, Volker Heinemann - European Journal of Cancer 2020 被引用: 25